The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism
Abstract
OBJECTIVE: Insulin resistance (IR) was reported to be associated with chronic heart failure (CHF). Adiponectin, an insulin-sensitizing hormone with anti-inflammatory activity, improves energy metabolism via AMP-activated protein kinase (AMPK). AMPK deficiency is associated with depressed cardiac function under stress conditions. However, it is not clear whether adiponectin plays an important role in CHF. We hypothesize that deficiency of adiponectin might result in deterioration of heart failure. METHODS: Using adiponectin null mice and their littermates, we examined the effects of adiponectin on LV pressure overload-induced cardiac hypertrophy and failure, and investigated the mechanisms involved. RESULTS: Three weeks after transverse aortic constriction (TAC), cardiac hypertrophy (evaluated from the heart-to-body weight ratio: 7.62+/-0.27 in wild-type (WT) mice, 9.97+/-1.13 in knockout (KO) mice, P<0.05) and pulmonary congestion (lung-to-body weight ratio: 9.05+/-1.49 in WT mice, 14.95+/-2.36 in KO mice, P<0.05) were significantly greater in adiponectin KO mice than WT mice. LV dimensions were also increased in KO mice. Compared with WT TAC mice, expression of AMPKalpha protein was lower, while IR was higher in KO TAC mice. CONCLUSION: These findings indicate that adiponectin deficiency leads to progressive cardiac remodeling in pressure overloaded condition mediated via lowing AMPK signaling and impaired glucose metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the use of adiponectin KO mice, it was shown that adiponectin deficiency enhanced progressive cardiac remodeling induced by surgical aortic constriction (208).”
From Cardiac remodeling in obesity (2008) · cites this paper as [208]
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,114
Self-citationMalik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L'Italien, G. J., Pio, J. R., & Williams, G. R. (2004) · Circulation · doi:10.1161/01.cir.0000140677.20606.0e · Cited by 1,837
Cited by
Sorted by citations
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Self-citationAdiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
Elumalai, A., & Jain, S. K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061321 · Cited by 1,206
Adiponectin as an anti-inflammatory factor
Ouchi, N., & Walsh, K. X. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.01.026 · Cited by 910
Self-citationAbel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736
Fuster, J. J., Ouchi, N., Gokce, N., & Walsh, K. X. (2016) · Circulation Research · doi:10.1161/circresaha.115.306885 · Cited by 691
Self-citationAdiponectin regulation and function
Fang, H., & Judd, R. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170046 · Cited by 631
Adipokines: A link between obesity and cardiovascular disease
Nakamura, K., Fuster, J. J., & Walsh, K. X. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.11.006 · Cited by 597
Metabolic Mechanisms in Heart Failure
Ashrafian, H., Frenneaux, M. P., & Opie, L. H. (2007) · Circulation · doi:10.1161/circulationaha.107.702795 · Cited by 522
AMPK alterations in cardiac physiology and pathology: enemy or ally?
Dyck, J. R. B., & Lopaschuk, G. D. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.109389 · Cited by 392
Inflammation and fibrosis in murine models of heart failure
Bacmeister, L., Schwarzl, M., Warnke, S., Stoffers, B., Blankenberg, S., Westermann, D., & Lindner, D. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0722-5 · Cited by 391
AMP-Activated Protein Kinase in the Heart
Arad, M., Seidman, C. E., & Seidman, J. G. (2007) · Circulation Research · doi:10.1161/01.res.0000258446.23525.37 · Cited by 357
Adiponectin actions in the cardiovascular system
Hopkins, T. A., Ouchi, N., Shibata, R., & Walsh, K. X. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.009 · Cited by 331
Self-citationCardiac Energy Metabolism in Obesity
Lopaschuk, G. D., Folmes, C. D. L., & Stanley, W. C. (2007) · Circulation Research · doi:10.1161/circresaha.107.150417 · Cited by 309
AMPK as a mediator of hormonal signalling
Lim, C. T., Kola, B., & Korbonits, M. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0063 · Cited by 304
Metformin Prevents Progression of Heart Failure in Dogs
Sasaki, H., Asanuma, H., Fujita, M., Takahama, H., Wakeno, M., Ito, S., Ogai, A., Asakura, M., Kim, J., Minamino, T., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.798561 · Cited by 291
Self-citationPacker, M. (2018) · Circulation · doi:10.1161/circulationaha.117.032474 · Cited by 263
Cardioprotection by Adiponectin
Ouchi, N., Shibata, R., & Walsh, K. X. (2006) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.03.001 · Cited by 260
Self-citationPatel, V. B., Mori, J., McLean, B. A., Basu, R., Das, S. K., Ramprasath, T., Parajuli, N., Penninger, J. M., Grant, M. B., Lopaschuk, G. D., et al. (2015) · Diabetes · doi:10.2337/db15-0399 · Cited by 260
Tsukamoto, O., Fujita, M., Kato, M., Yamazaki, S., Asano, Y., Ogai, A., Okazaki, H., Asai, M., Nagamachi, Y., Maeda, N., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.038 · Cited by 251
Self-citationAMP-activated protein kinase, stress responses and cardiovascular diseases
Wang, S., Song, P., & Zou, M. (2012) · Clinical Science · doi:10.1042/cs20110625 · Cited by 251
Adiponectin and Cardiovascular Disease
Shibata, R., Ouchi, N., & Murohara, T. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0057 · Cited by 214
Self-citationAdiponectin protects against the development of systolic dysfunction following myocardial infarction
Shibata, R., Izumiya, Y., Sato, K., Papanicolaou, K. N., Kihara, S., Colucci, W. S., Sam, F., Ouchi, N., & Walsh, K. X. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.03.808 · Cited by 213
Self-citationMurine Models of Heart Failure With Preserved Ejection Fraction
Valero‐Muñoz, M., Backman, W., & Sam, F. (2017) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.07.013 · Cited by 217
Expanding role of AMPK in endocrinology
Kola, B., Boscaro, M., Rutter, G. A., Grossman, A. B., & Korbonits, M. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.05.006 · Cited by 200
Beauloye, C., Bertrand, L., Horman, S., & Hue, L. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr034 · Cited by 191
Zhang, P., Hu, X., Xu, X. Y., Fassett, J., Zhu, G., Viollet, B., Xu, W. W., Wiczer, B. M., Bernlohr, D., Bache, R. J., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114702 · Cited by 190
Adiponectin Protects Against Angiotensin II–Induced Cardiac Fibrosis Through Activation of PPAR-α
Fujita, K., Maeda, N., Sonoda, M., Ohashi, K., Hibuse, T., Nishizawa, H., Nishida, M., Hiuge, A., Kurata, A., Kihara, S., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.156687 · Cited by 185
Self-citationThe Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
Packer, M. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.06.055 · Cited by 213
Adipokines, Myokines and Cardiovascular Disease
Walsh, K. X. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0961 · Cited by 178
AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease
Wong, A., Howie, J., Petrie, J. R., & Lang, C. C. (2009) · Clinical Science · doi:10.1042/cs20080066 · Cited by 170
Viollet, B., Mounier, R., Leclerc, J., Yazigi, A., Foretz, M., & Andréelli, F. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.10.004 · Cited by 168
Guo, R., Zhang, Y., Turdi, S., & Ren, J. T. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.013 · Cited by 165
AMPK: A cellular metabolic and redox sensor. A minireview
Shirwany, N. A. (2014) · Frontiers in bioscience · doi:10.2741/4218 · Cited by 143
Wang, Y., Gao, E., Tao, L., Lau, W. B., Yuan, Y., Goldstein, B. J., Lopez, B. L., Christopher, T. A., Tian, R., Koch, W. J., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.815043 · Cited by 136
Adiponectin as a potential biomarker of vascular disease
Mohammadi, S., Arefhosseini, S. R., Ebrahimi‐Mameghani, M., Fallah, P., & Bazi, Z. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s48753 · Cited by 129
Role of adiponectin in the regulation of carbohydrate and lipid metabolism.
Karbowska, J., & Kochan, Z. (2006) · PubMed · Cited by 126
Adiponectin in Cardiovascular Inflammation and Obesity
Aprahamian, T. R., & Sam, F. (2011) · International Journal of Inflammation · doi:10.4061/2011/376909 · Cited by 122
The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
Chakaroun, R., Olsson, L. M., & Bäckhed, F. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00771-0 · Cited by 131
Amin, R., Mathews, S. T., Camp, H. S., Ding, L., & Leff, T. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00446.2009 · Cited by 120
Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart
Karmazyn, M., Purdham, D. M., Rajapurohitam, V., & Zeidan, A. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn115 · Cited by 118
PALANIVEL, R., FANG, X., PARK, M., EGUCHI, M., PALLAN, S., DEGIROLAMO, S., LIU, Y., WANG, Y., XU, A., & SWEENEY, G. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.011 · Cited by 117
An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart
Fang, X., Palanivel, R., Cresser, J., Schram, K., Ganguly, R., Thong, F. S. L., Tuinei, J., Xu, A., Abel, E. D., & Sweeney, G. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00086.2010 · Cited by 119
Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling
Essick, E. E., Ouchi, N., Wilson, R. M., Ohashi, K., Ghobrial, J. M., Shibata, R., Pimentel, D. R., & Sam, F. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00428.2011 · Cited by 111
Self-citationCardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?
Elrakaybi, A., Laubner, K., Zhou, Q., Hug, M. J., & Seufert, J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101549 · Cited by 117
Shimano, M., Ouchi, N., Shibata, R., Ohashi, K., Pimentel, D. R., Murohara, T., & Walsh, K. X. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.02.021 · Cited by 111
Self-citationDuda, M. K., O’Shea, K. M., LEI, B., Barrows, B. R., Azimzadeh, A., McElfresh, T. A., Hoit, B. D., Kop, W. J., & Stanley, W. C. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.07.002 · Cited by 105
Kang, S., Chemaly, E. R., Hajjar, R. J., & Lebeche, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200022 · Cited by 110
AMP-Activated Protein Kinase and Metabolic Control
Viollet, B., & Andréelli, F. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_13 · Cited by 113
Kruszewska, J., Cudnoch‐Jędrzejewska, A., & Czarzasta, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084195 · Cited by 113
Adiponectin resistance in skeletal muscle: Pathophysiological implications in chronic heart failure
Sente, T., Van Berendoncks, A. M., Hoymans, V. Y., & Vrints, C. J. (2016) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12086 · Cited by 95
The Role of AMP-Activated Protein Kinase in Obesity
Kola, B., Grossman, A. B., & Korbonits, M. (2008) · KARGER eBooks · doi:10.1159/000115366 · Cited by 100
Adiponectin Action: A Combination of Endocrine and Autocrine/Paracrine Effects
Dadson, K., Liu, Y., & Sweeney, G. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00062 · Cited by 100
Xu, X., Hua, Y., Nair, S., Bucala, R., & Ren, J. T. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02219 · Cited by 97
Lopez, M., Lax, A., Pascual-Figal, D. A., Valdés, M., & Sánchez‐Más, J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.015 · Cited by 99
Shibata, R., Sato, K., Kumada, M., Izumiya, Y., Sonoda, M., Kihara, S., Ouchi, N., & Walsh, K. X. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.02.010 · Cited by 93
Self-citationAdipocytokines, cardiovascular pathophysiology and myocardial protection
Smith, C., & Yellon, D. M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.003 · Cited by 96
Tamura, T., Furukawa, Y., Taniguchi, R., Sato, Y., Ono, K., Horiuchi, H., Nakagawa, Y., Kita, T., & Kimura, T. (2007) · Circulation Journal · doi:10.1253/circj.71.623 · Cited by 91
Kondo, K., Shibata, R., Unno, K., Shimano, M., Ishii, M., Kito, T., Shintani, S., Walsh, K. X., Ouchi, N., & Murohara, T. (2010) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.109.872044 · Cited by 89
Self-citationMetformin improves cardiac function in rats via activation of AMP‐activated protein kinase
Wang, X., Zhang, J., Li, L., Zhao, X., Tao, H., & Zhang, L. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05470.x · Cited by 89
Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy
Skurk, C., Wittchen, F., Suckau, L., Witt, H., Noutsias, M., Fechner, H., Schultheiss, H.-P., & Poller, W. C. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn136 · Cited by 86
Nakamura, T., Funayama, H., Kubo, N., Yasu, T., Kawakami, M., Saito, M., Momomura, S.-I., & Ishikawa, S.-E. (2006) · Circulation Journal · doi:10.1253/circj.70.1557 · Cited by 84
Cardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction
Varjabedian, L., Bourji, M., Pourafkari, L., & Nader, N. D. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-0266-3 · Cited by 85
Boyle, J. G., Salt, I. P., & McKay, G. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03098.x · Cited by 83
Raher, M. J., Thibault, H., Buys, E. S., Kuruppu, D., Shimizu, N., Brownell, A., Blake, S. L., Rieusset, J., Kaneki, M., Dérumeaux, G., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00139.2008 · Cited by 82
Liu, G., Ding, M., Chiuve, S. E., Rimm, E. B., Franks, P. W., Meigs, J. B., Hu, F. B., & Sun, Q. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308320 · Cited by 80
Adiponectin Synthesis, Secretion and Extravasation from Circulation to Interstitial Space
Rosa, S. C. D. S., Liu, M., & Sweeney, G. (2021) · Physiology · doi:10.1152/physiol.00031.2020 · Cited by 80
Direct effects of adipokines on the heart: focus on adiponectin
Park, M. S., & Sweeney, G. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9337-8 · Cited by 79
Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats
Guo, Z., Xia, Z., Yuen, V. G., & McNeill, J. H. (2007) · Metabolism · doi:10.1016/j.metabol.2007.05.005 · Cited by 77
AMPK isoform expression in the normal and failing hearts
Kim, M., Shen, M., Ngoy, S., Karamanlidis, G., Liao, R., & Tian, R. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.01.016 · Cited by 75
Sharma, A. X., Quittner-Strom, E. B., Lee, Y., Johnson, J. A., Martin, S. A., Yu, X., Li, J., Lu, J., Cai, Z. P., Chen, S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.065 · Cited by 71
Microbially Produced Imidazole Propionate Is Associated With Heart Failure and Mortality
Molinaro, A., Nemet, I., Lassen, P. B., Chakaroun, R., Nielsen, T., Aron‐Wisnewsky, J., Bergh, P., Li, L., Henricsson, M., Køber, L., et al. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.03.008 · Cited by 72
Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy
SHARMA, N., Okere, I. C., Duda, M. K., Chess, D. J., O’Shea, K. M., & Stanley, W. C. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.11.007 · Cited by 69
Adipocytokines and obesity-linked disorders.
Ouchi, N., Ohashi, K., Shibata, R., & Murohara, T. (2012) · PubMed Central · doi:10.18999/nagjms.74.1-2.19 · Cited by 67
Self-citationMcManus, D. D., Lyass, A., Ingelsson, E., Massaro, J. M., Meigs, J. B., Aragam, J. R., Benjamin, E. J., & Vasan, R. S. (2011) · Obesity · doi:10.1038/oby.2011.32 · Cited by 68
Resistin, an adipocytokine, offers protection against acute myocardial infarction
Gao, J., Chua, C. C., Chen, Z., Wang, H., Xu, X., Hamdy, R. C., McMullen, J. R., Shioi, T., Izumo, S., & Chua, B. H. L. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.009 · Cited by 67
Metabolic Shifts during Aging and Pathology
Ma, Y., & Li, J. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140041 · Cited by 75
Tanaka, K., Wilson, R. M., Essick, E. E., Duffen, J., Scherer, P. E., Ouchi, N., & Sam, F. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001279 · Cited by 67
Self-citationCardiometabolic effects of adiponectin
Parker, J., & Walsh, K. X. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.09.001 · Cited by 64
Diabetic cardiomyopathy: signaling defects and therapeutic approaches
Dobrin, J. S., & Lebeche, D. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.17 · Cited by 63
Adiponectin Level and Left Ventricular Hypertrophy in Japanese Men
Mitsuhashi, H., Yatsuya, H., Tamakoshi, K., Matsushita, K., Otsuka, R., Wada, K., Sugiura, K., Takefuji, S., Hotta, Y., Kondo, T., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.079509 · Cited by 64
Adiponectin--an adipokine with unique metabolic properties
Wiecek, A., Adamczak, M., & Chudek, J. T. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl814 · Cited by 63
Takahashi, A., Asakura, M., Ito, S., Min, K.-D., Shindo, K., Yan, Y., Liao, Y., Yamazaki, S., Sanada, S., Asano, Y., et al. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00454.2012 · Cited by 61
Self-citationBack to the heart: The protective role of adiponectin
Caselli, C., D’Amico, A., Cabiati, M., Prescimone, T., Ry, S. D., & Giannessi, D. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.03.003 · Cited by 61
Insulin decreases myocardial adiponectin receptor 1 expression via PI3K/Akt and FoxO1 pathway
Cui, X., Wang, C., Li, L., Dong, F., Zhou, Y., Wu, D., Cui, Q., Fu, F.-Y., & Wu, L. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr273 · Cited by 59
Shibata, R., Numaguchi, Y., Matsushita, K., Sone, T., Kubota, R., Ohashi, T., Ishii, M., Kihara, S., Walsh, K. X., Ouchi, N., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.057 · Cited by 59
Self-citationCirculating Adiponectin Levels in Patients With Atrial Fibrillation
Shimano, M., Shibata, R., Tsuji, Y., Kamiya, H., Uchikawa, T., Harata, S., Muto, M., Ouchi, N., Inden, Y., & Murohara, T. (2008) · Circulation Journal · doi:10.1253/circj.72.1120 · Cited by 58
Self-citationde Oliveira, A. C., Andreotti, S., de Farias, T. D. S. M., Torres‐Leal, F. L., de Proença, A. R. G., Campaña, A. B., de Souza, A. H., Sertié, R. A. L., Carpinelli, Â. R., Cipolla‐Neto, J., et al. (2012) · Endocrinology · doi:10.1210/en.2011-1675 · Cited by 55
Summer, R. S., Walsh, K. X., & Medoff, B. D. (2011) · Pulmonary Circulation · doi:10.4103/2045-8932.93542 · Cited by 52
Bobbert, P., Scheibenbogen, C., Jenke, A., Kania, G., Wilk, S., Krohn, S., Stehr, J., Kühl, U., Rauch, U., Eriksson, U., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq498 · Cited by 53
The cardio-protective signaling and mechanisms of adiponectin.
Nanayakkara, G., Kariharan, T., Wang, L., Zhong, J., & Amin, R. (2012) · PubMed Central · Cited by 51
Wang, Y., Gao, E., Lau, W. B., Wang, Y., Liu, G., Li, J., Wang, X., Yuan, Y., Koch, W. J., & Ma, X. (2015) · Circulation · doi:10.1161/circulationaha.114.015248 · Cited by 49
Effect of Atrial Natriuretic Peptide on Adiponectin in Patients with Heart Failure
Tanaka, T., Tsutamoto, T., Sakai, H., Nishiyama, K., Fujii, M., Yamamoto, T., & Horie, M. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.02.005 · Cited by 50
Reis, J. P., Allen, N. B., Gibbs, B. B., Gidding, S. S., Lee, J. M., Lewis, C. E., Lima, J. A. C., Lloyd‐Jones, D. M., Loria, C. M., Powell‐Wiley, T. M., et al. (2014) · Obesity · doi:10.1002/oby.20865 · Cited by 48
Cardiopulmonary Dysfunction and Adiponectin in Adolescents With Type 2 Diabetes
Bjornstad, P., Truong, U. T., Dorosz, J. L., Cree‐Green, M., Baumgartner, A., Coe, G. V., Pyle, L., Regensteiner, J. G., Reusch, J. E. B., & Nadeau, K. J. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002804 · Cited by 47
Zhang, N., Wei, W., Liao, H.-H., Yang, Z., Hu, C., Wang, S., Deng, W., & Tang, Q. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1696-8 · Cited by 48
Impacts of a high-fat diet on the metabolic profile and the phenotype of atrial myocardium in mice
Suffee, N., Baptista, E., Piquereau, J., Ponnaiah, M., Doisne, N., Ichou, F., Lhomme, M., Pichard, C., Galand, V., Mougenot, N., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab367 · Cited by 47
Adiponectin and Risk of Congestive Heart Failure
Ingelsson, E., Risérus, U., Berne, C., Frystyk, J., Flyvbjerg, A., Axelsson, T., Lundmark, P., & Zethelius, B. (2006) · JAMA · doi:10.1001/jama.295.15.1772-c · Cited by 47
Amin, R., Mathews, S. T., Alli, A., & Leff, T. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01032.2009 · Cited by 45
The Pathophysiology of Cardiac Hypertrophy and Heart Failure
Stansfield, W. E., Ranek, M. J., Pendse, A. A., Schisler, J. C., Wang, S., Pulinilkunnil, T., & Willis, M. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405206-2.00004-1 · Cited by 46
Metadata
- Authors
- LIAO, Y., TAKASHIMA, S., MAEDA, N., OUCHI, N., KOMAMURA, K., SHIMOMURA, I., HORI, M., MATSUZAWA, Y., FUNAHASHI, T., & KITAKAZE, M.
- Affiliations
- The University of Osaka (JP)
- National Cerebral and Cardiovascular Center (JP)
- Corresponding author
- KITAKAZE, M
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 67
- Issue
- 4
- Pages
- 705-713
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2148710672
- Cited by
- 236
- References
- 48
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 1 · 2023: 8 · 2022: 9 · 2021: 4 · 2020: 6 · 2019: 6 · 2018: 13 · 2017: 9 · 2016: 9 · 2015: 15 · 2014: 13 · 2013: 10 · 2012: 16
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- adiponectin, heart failure, AMPK, AMPKα, insulin resistance, glucose metabolism, cardiac hypertrophy, pressure overload, transverse aortic constriction, cardiac remodeling, adiponectin knockout mice, pulmonary congestion
- MeSH terms
- Adenylate Kinase, Animals, Blood Glucose, Echocardiography, Fasting, Heart Failure, Insulin, Insulin Resistance, Male, Myocardium, Blotting, Western, Mice, Knockout, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review